Henry Schein Announces Appointment of Three New Members to the Company’s Executive Management Committee
April 10 2024 - 4:05PM
Business Wire
Joining Henry Schein’s EMC are Steve Boggan
and Bianka Wilson, Co-CEOs of the Global Oral Reconstruction Group,
and Tom Popeck, CEO of the Healthcare Specialties Group
Henry Schein, Inc. (NASDAQ: HSIC), the world’s largest provider
of healthcare solutions to office-based dental and medical
practitioners, today announced that it has appointed three new
members to the Company’s Executive Management Committee (EMC) –
Steve Boggan and Bianka Wilson, who were recently named Co-CEOs of
the Company’s Global Oral Reconstruction Group (GORG), and Tom
Popeck, CEO of the Company’s Healthcare Specialties Group
(HSG).
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240410230713/en/
Bianka Wilson, Co-Chief Executive
Officer, Global Oral Reconstruction Group, Henry Schein, Inc.
(Photo: Business Wire)
GORG includes the Company's comprehensive portfolio of premium
value and value implant lines and a full range of biomaterial
products. HSG includes a range of company-owned manufacturing
brands in the high-growth endodontic, orthodontic, and orthopedic
markets.
“We are delighted to welcome three strong and proven leaders to
the Henry Schein Executive Management Committee,” said Stanley
Bergman, Chairman and Chief Executive Officer of Henry Schein, Inc.
“Steve, Bianka, and Tom have each demonstrated vision and
commitment in inspiring and leading our teams to excellence in a
quickly changing global healthcare marketplace. Our senior
leadership team will benefit greatly from the added perspectives of
these seasoned professionals.”
The GORG and HSG businesses are central to advancing the
Company’s BOLD+1 strategic plan, in particular the building of
higher-growth and higher-margin specialty products and services
offerings that complement our distribution, software, and
value-added businesses. Together, the Company is leveraging these
businesses to broaden and deepen relationships with customers.
Mr. Boggan joined Henry Schein in 2013 with the Company’s
acquisition of BioHorizons, which he joined as a start-up in 1995
and has led as President and CEO since 1999. As Co-CEO of GORG, Mr.
Boggan will lead commercial operations in North and South America
and the Middle East as well as global marketing.
Ms. Wilson joined Henry Schein in 2018 after a successful
25-year career in finance and consulting. Prior to Henry Schein,
she served as Group CFO of Ascom Holding AG, a Swiss public company
in the medical communication technology sector and, prior to that,
as Advisory and Global Account Lead Partner at KPMG. Ms. Wilson had
been serving as Chief Financial Officer of GORG and, as Co-CEO, she
will lead strategy, finance, and human resources as well as the
group’s business in Europe and APAC.
Mr. Popeck joined Henry Schein in 2019 with more than 20 years
of sales leadership and general management experience, including
extensive experience in the medical device sector. Prior to joining
Henry Schein, he spent over two decades leading businesses in
orthopedics and industrial manufacturing, including spending 11
years at Stryker, where he held various leadership roles, including
leading Stryker’s Foot & Ankle business unit as Vice President
and General Manager. In 2023, he was promoted to President of Henry
Schein’s Healthcare Specialties Group.
About Henry Schein, Inc.
Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for
health care professionals powered by a network of people and
technology. With more than 25,000 Team Schein Members worldwide,
the Company's network of trusted advisors provides more than 1
million customers globally with more than 300 valued solutions that
help improve operational success and clinical outcomes. Our
Business, Clinical, Technology, and Supply Chain solutions help
office-based dental and medical practitioners work more efficiently
so they can provide quality care more effectively. These solutions
also support dental laboratories, government and institutional
health care clinics, as well as other alternate care sites.
Henry Schein operates through a centralized and automated
distribution network, with a selection of more than 300,000 branded
products and Henry Schein private-brand products in stock.
A FORTUNE 500 Company and a member of the S&P 500® index,
Henry Schein is headquartered in Melville, N.Y., and has operations
or affiliates in 33 countries and territories. The Company's sales
reached $12.3 billion in 2023, and have grown at a compound annual
rate of approximately 11.5 percent since Henry Schein became a
public company in 1995.
For more information, visit Henry Schein at www.henryschein.com,
Facebook.com/HenrySchein, Instagram.com/HenrySchein, and
@HenrySchein on X.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240410230713/en/
Investors: Ronald N. South Senior Vice President and Chief
Financial Officer ronald.south@henryschein.com (631) 845-2802
Graham Stanley Vice President, Investor Relations and Strategic
Financial Project Officer graham.stanley@henryschein.com (631)
843-5963
Media: Ann Marie Gothard Vice President, Global Corporate Media
Relations annmarie.gothard@henryschein.com (631) 390-8169
Henry Schein (NASDAQ:HSIC)
Historical Stock Chart
From Apr 2024 to May 2024
Henry Schein (NASDAQ:HSIC)
Historical Stock Chart
From May 2023 to May 2024